Clinical Trial

Efficacy and Safety of Lactoferrin in Heart Failure Patients

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study will be conducted to determine the efficacy and safety of lactoferrin versus oral iron versus lactoferrin plus oral iron as an add on therapy in reduced ejection fraction heart failure patients with iron deficiency. •Patients will be randomly distributed into the three groups * All patients will be subjected to baseline data assessment * Follow up after 12 weeks
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-05-18.
Trial Details
NCT Number NCT06427200
Lead Sponsor Cairo University
Conditions Heart Failure With Reduced Ejection Fraction
Enrollment 114 participants
Start Date 2024-07
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2024-05-24